Participating Faculty

Supplements and Featured Publications, Managing the Expanded Use of Biologics Across Therapeutic Areas: An Example From B-Cell Targeted The, Volume 12, Issue 2 Suppl

The American Journal of Managed Care

This supplement to features a review article that examines the expanded use of biologics across therapeutic areas, using B-cell targeted therapies as an example. This supplement has been peer reviewed by an expert in the field.

Faculty

Marc Cohen, MD

Mayo Clinic

Vice President and Medical Director Matria Healthcare

Principal and Co-founder

University Place, Washington

Faculty Disclosures

Marc Cohen, MD, reports that he has (or an immediate family member has) a vested interest in or affiliation with a corporate organization offering financial support or grant monies for this continuing education activity or with an organization that has a specific interest in the therapeutic areas under discussion, as follows: he has received grant/research support from Abbott Laboratories; Amgen, Inc; Wyeth Pharmaceuticals; Centacor, Inc; Genentech, Inc; and TAP Pharmaceutical Products, Inc.

Thomas Morrow, MD, reports that he (nor does any immediate family member) does not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity or any affiliation with an organization whose philosophy could potentially bias his involvement in this activity.

Peter Penna, PharmD, reports that he (nor does any immediate family member) does not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity or any affiliation with an organization whose philosophy could potentially bias his involvement in this activity.

The American Journal of Managed Care,

Signed disclosures are on file at the offices of Jamesburg, New Jersey.

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The University of Utah College of Pharmacy and the University of Utah School of Medicine do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Utah College of Pharmacy or the University of Utah School of Medicine. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Americans with Disabilities Act (ADA): The University of Utah College of Pharmacy and the University of Utah School of Medicine complies with the ADA by providing qualified individuals with disabilities access to University programs, services, and activities. A request for accommodation can be made by calling (801) 483-3039. Reasonable prior notice is required.